Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma

Docetaxel, cisplatin, and 5‐fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal adenocarcinoma (GEA). The aim of this study was to assess efficacy of DCF regimen as perioperative chemotherapy compared with surgery alone in patients with resectable GEA. We identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiteni, Frédéric, Paget‐Bailly, Sophie, Messager, Mathieu, N'Guyen, Thierry, Lakkis, Zaher, Mathieu, Pierre, Lamfichekh, Najib, Picard, Alain, Benzidane, Bilell, Cléau, Denis, Bonnetain, Franck, Borg, Christophe, Mariette, Christophe, Kim, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119963/
https://www.ncbi.nlm.nih.gov/pubmed/27726290
http://dx.doi.org/10.1002/cam4.885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119963/
https://www.ncbi.nlm.nih.gov/pubmed/27726290
http://dx.doi.org/10.1002/cam4.885

Ejemplares similares